Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Editorial
Nature Biotechnology 20, 1 (1 January 2002) | doi:10.1038/nbt0102-1
Publish and be damned
Abstract
The festive season traditionally serves up fare that wreaks havoc on the digestive system. However, the fodder served up by privately held biotechnology company Advanced Cell Technology last November virtually guaranteed heartburn and dyspepsia for those of us committed to the progress of biotechnology research.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
